Personne
Alan Nicolas Thierry Guichard
Cette personne n’est plus à l’EPFL
Publications associées (4)
Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models
Michele De Palma, Nadine Fournier, Alan Nicolas Thierry Guichard, Bruno Torchia, Etienne Meylan, Chiara Cianciaruso, Sina Nassiri, Ioanna Keklikoglou, Ece Kadioglu, Gael Luis Boivin, Amaia Martinez Usatorre
Immune checkpoint blockade (ICB) with PD-1 or PD-L1 antibodies has been approved for the treatment of nonsmall cell lung cancer (NSCLC). However, only a minority of patients respond, and sustained remissions are rare. Both chemotherapy and antiangiogenic d ...
AMER ASSOC ADVANCEMENT SCIENCE2021Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy
Michele De Palma, Alan Nicolas Thierry Guichard, Nicolo Rigamonti, Daniela Pais Ferreira
Cancer immunotherapies are increasingly combined with targeted therapies to improve therapeutic outcomes. We show that combination of agonistic anti-CD40 with antiangiogenic antibodies targeting 2 proangiogenic factors, vascular endothelial growth factor A ...
2020Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice
Matthias Lütolf, Michele De Palma, Alan Nicolas Thierry Guichard, Mauro Delorenzi, Mario Leonardo Squadrito, Sina Nassiri, Nikolche Gjorevski, Simone Ragusa, Borja Prat Luri, Laureline Wetterwald
Mutations in APC promote colorectal cancer (CRC) progression through uncontrolled WNT signaling. Patients with desmoplastic CRC have a significantly worse prognosis and do not benefit from chemotherapy, but the mechanisms underlying the differential respon ...
2020Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
Michele De Palma, Alan Nicolas Thierry Guichard, Mario Leonardo Squadrito, Chiara Cianciaruso, Esra Güç, Ioanna Keklikoglou, Antonino Cassarà
Cytotoxic chemotherapy is an effective treatment for invasive breast cancer. However, experimental studies in mice also suggest that chemotherapy has pro-metastatic effects. Primary tumours release extracellular vesicles (EVs), including exosomes, that can ...
2019